- ARAB NEWS
- 01 May 2025
Since 1975
BEIJING: The Avigan influenza drug developed by an affiliate of Japan's Fujifilm Holdings Corp. has been confirmed by clinical tests to be effective in treating patients with COVID-19, caused by the new coronavirus, China's science and technology ministry has said.
In the clinical tests at hospitals in Wuhan, Hubei Province, and Shenzhen, Guangdong Province, patients given the drug were quicker to turn negative for the coronavirus and see their pneumonia symptoms improve, according to the Chinese ministry.
In Japan, the administration of Avigan to treat COVID-19 patients started last month.
Major Chinese drug maker Zhejiang Hisun Pharmaceutical Co. plans to produce a generic drug of Avigan, based on a license agreement it concluded with Fujifilm in 2016.
JIJI Press
